Ryan Preblick
Director of Finance/CFO presso INDIVIOR PLC
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INDIVIOR PLC
0.05% | 15/03/2024 | 68 386 ( 0.05% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Ryan Preblick
| Società | Posizione | Inizio |
|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 29/06/2020 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formazione di Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Borsa valori
- Insiders
- Ryan Preblick
